Board decision to fund Estradot and Oestradiol TDP Mylan
Board paper to fund Estradot and Estradiol TDP Mylan
The paper gives Pharmac's Board the information it needs to make its decision to fund both Estradot and Estradiol TDP Mylan from 1 December 2025.
Some information has been removed in line with the Official Information Act. We did this to:
- protect the commercial position of the people who supplied Pharmac information (section 9(2)(b)(ii))
- ensure Pharmac can continue to receive confidential information from pharmaceutical suppliers (section 9(2)(ba)(i))
- ensure Pharmac can continue to negotiate effectively on behalf of New Zealanders for pharmaceuticals (section 9(2)(j)).
We have previously released information on our funding decisions for oestradiol patches.